A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol.
Lee EK, Kang YE, Park YJ, Koo BS, Chung KW, Ku EJ, Won HR, Yoo WS, Jeon E, Paek SH, Lee YS, Lim DM, Suh YJ, Park HK, Kim HJ, Kim BH, Kim M, Kim SW, Yi KH, Park SK, Jung EJ, Choi JY, Bae JS, Hong JH, Nam KH, Lee YK, Yu HW, Go S, Kang YM; MASTER study group.
Lee EK, et al. Among authors: lim dm.
Endocrinol Metab (Seoul). 2021 Jun;36(3):574-581. doi: 10.3803/EnM.2020.943. Epub 2021 May 26.
Endocrinol Metab (Seoul). 2021.
PMID: 34034365
Free PMC article.